Al-Azhar university
Damietta, Egypt
NCT Number: NCT06752278
Management approaches for dry eye disease (DED) typically start with low-risk, easily accessible, patient-applied therapies like artificial tears for early-stage disease. As the condition worsens, treatment progresses to more advanced therapies for severe forms of DED. This study aims to compare the effectiveness and safety of pilocarpine as a secretagogue versus artificial tears in the treatment of dry eye disease. Our goal is to provide reliable, high-quality evidence regarding the efficacy of secretagogues, thereby contributing to the development of recommendations that aid clinicians in their decision-making process
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Damietta, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pilocarpine is a muscarinic agonist
artificial tears used for the treatment of Dry eye
Time frame: At the baseline and after 6 weeks
Time frame: At the baseline and after 6 weeks
Al-Azhar University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07234318
Dry Eye Disease (DED), Dry Eye Syndromes
Vienna, Austria
View Trial DetailsNCT07639034
Dry Eye Disease (DED), Dry Eye Syndromes
La Jolla, California, United States
View Trial DetailsNCT07588074
Conjunctival Diseases, Conjunctivitis
Baton Rouge, Louisiana, United States
View Trial DetailsNCT07060131
Dry Eye Disease (DED), Dry Eye Syndromes
Taichung, North Dist, Taiwan
View Trial Details